Takara Holdings Inc.
Notice of Postponement of Announcement Date for Q1 Fiscal Year Ending March 2027 Financial Results
The Q1 financial results announcement for the fiscal year ending March 2027 has been postponed while investigating uncertainties in the accounting treatment of Takara Bio USA, Inc. The new Q1 announcement date is October 23, 2026, and the Q2 results are scheduled to be announced on November 10, 2026.
Key Figures
- Announcement Date: 2026-10-23
- Q2 Financial Results Announcement Date: 2026-11-10
AI要約
Background of Delay and Investigation
Following a notice published on August 12, 2026 that disclosure of the Q1 financial summary for the fiscal year ending March 2027 would exceed 45 days after the quarter-end, the company has been investigating uncertainties in the accounting treatment of Takara Bio USA, Inc. With the investigation completed and a timeline for the financial announcement established, the company has set the Q1 financial results announcement date to October 23, 2026. The Q2 financial results are scheduled to be announced on November 10, 2026.
Future Schedule and Shareholder Communication
The company apologizes for any confusion caused to shareholders and investors by the change in the announcement date. The scheduled Q2 announcement date has also been disclosed, and the company intends to continue timely disclosure of information.
Takara Holdings Inc.
Company overview · Stock price · Financial data · All IR
